| Nov 4 |
Renovaro Issues Shareholder Letter and Provides Corporate Update
|
| Oct 30 |
Renovaro files for $200M mixed securities shelf
|
| Oct 17 |
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
|
| Oct 16 |
Renovaro Announces Strategic Restructuring and Leadership Transition
|
| Sep 19 |
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
|
| Sep 17 |
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
|
| Sep 13 |
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
|
| Sep 11 |
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
|
| Jul 31 |
Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
|
| Jul 26 |
The Junk in Your Index Fund Is Costing You Big-Time
|
